UBR1 and BRCC36 regulate ACE2 Ubiquitination and Deubiquitination in Ang-II induced Hypertension.
Navya Lakkappa
1
, Clara Berdasco
1
, Catalin Filipeanu
2
, Eric Lazartigues
1
1. Pharmacology, LSUHSC, New Orleans, LA; 2. Pharmacology, Howard University, Washington, DC. ACE2 is undergoing Ang-II-mediated internalization, ubiquitination and degradation, contributing to hypertension. Using proteomics and bioinformatic analysis, we identified UBR1 and BRCC36 and evaluated their role in ACE2 ubiquitination in hypertension. Following gonadectomy, blood pressure (BP, telemetry) was recorded in C57BL6/J mice (3-month-old, n=10/group) infused with Ang-II (490 ng/Kg/min/4 weeks sc). UBR1, BRCC36 and ACE2 expression was assessed in heart and kidneys (capillary western). Ang-II infusion induced a significant mean BP increase in all groups (sham males: 133 ±0.6; castrated: 141 ±0.6; sham females: 134 ±0.7; ovariectomized: 130 ±0.3 mmHg; n=6, one-way ANOVA, P<0.001). UBR1 levels were similar between sexes while cardiac BRCC36 was 2-fold higher in females (P<0.001). Ang-II-mediated hypertension led to a 4-fold increase in UBR1 in males heart and kidneys (P<0.001) and a 2-fold increase in females (P<0.01) while gonadectomy blunted this effect by 50%. Castration did not affect BRCC36 levels while ovariectomy reduced them by 5-fold. Males infused with Ang-II showed no significant change in BRCC36 expression while hypertensive females had a dramatic reduction (5-fold, P<0.001) in the heart. Overall, UBR1 was associated with a reduction and BRCC36 was associated with an increase of ACE2 levels. Endothelial cells (HAEC) exposed to Ang-II (100 nM for 4h) had a 2-fold increase in UBR1 and a 10-fold reduction in ACE2 (n=3: one-way ANOVA, P< 0.01). Complete knockdown of UBR1 resulted in a 10-fold increase in ACE2 levels (n=3: one-way ANOVA, P<0.05). In HEK293T cells transfection with BRCC36 reversed the Ang-II effects (72533.5 ±4432.2
vs.
42204.2 ±4338.7; FU/min/μg protein, n=3, one-way ANOVA, P<0.05). Together, we show that ACE2 expression in hypertension is differentially regulated by URB1 and BRCC36 and depends on sex hormones. Inhibition of UBR1 and upregulation of BRCC36 could be a new therapeutic strategy to prevent ACE2 ubiquitination in hypertension.